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ABSTRACT
Background: Our study evaluates surgical outcomes 
of patients treated for perihilar cholangiocarcinoma 
in a single institution and demonstrates postoperative 
(90 days) morbidity and mortality rates and potential 
prognostic factors associated with complications.
Methods: Medical records of all patients with a diagnosis 
of perihilar cholangiocarcinoma (pCC) between 2007 
and 2017 who underwent a surgical procedure at the 
University hospital centre Zagreb, were retrospectively 
evaluated. Statistical analysis to determine predictors 
of postoperative mortality was performed using the 
Chi-square test and Fisher exact probability test where 
appropriate.
Results: Out of 52 surgically treated patients, 43 
underwent radical and 9 palliative procedures. 
Hilar resection and hilar resection along with right 
hepatectomy were the most commonly performed 
procedures in 34 radically treated patients. Overall 
morbidity and mortality rates were 46% and 5.7%, 
respectively. Significantly higher morbidity rate 
was observed in a group of patient with untreated 
preoperative jaundice and in those aged 70 and over.
Conclusion: Current guidelines favor extension of 
radicality in treatment of pCC by performing left or 
right hepatectomy in addition to hilar resection. This 
may increase R0 resection rates and prolong disease 
free survival. Our experience shows similar mortality/
morbidity rates as reported in other centers and confirms 
that in selected patients, concomitant hepatectomy for 
perihilar pCC is a safe and feasible surgical strategy.
Keywords: 
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Introduction
Perihilar cholangicarcinoma (pHCC) is the second most 
common primary cancer of the liver with a generally 
poor prognosis and it represents a difficult challenge for 
hepatobilliary surgeons not just because of aggressive 
nature of the cancer, but also because of variable anatomical 
relations of hillar structures. Historically, the surgery for this 
cancer was characterized by high mortality rates but also 
surgeons were confronted with a low resectability rate (up 
to to 50%) and high recurrence rates (50% to 70%) [1,2].
However, over the last decade, studies suggest some 
progress in treatment and slight improvement in 
outcome that have mainly derived from a better 
understanding of the tumor spread and improved 
technique of liver parenchymal transection [3].
In addition, it can be also explained by wider indications 
and adopting more radical surgical procedures that 
include standard or extended hepatectomies along 
with resection of extrahepatic biliary ducts and portal 
vein/hepatic artery if necessary.
Material and Methods
Our paper is a review of 10 years’ experience with 
574 resections for perihilar cholangio- carcinoma in 
a tertiary institution. Medical records of all patients 
with a diagnosis of perihilar cholangiocarcinoma 
(pCC) between 2007 and 2017 who underwent 
surgical procedure at our surgical department were 
retrospectively evaluated.
We demonstrate demographic and baseline patient 
characteristics, intraoperative factors and outcome in 
terms of morbidity mortality and 1 year disease free 
survival. Results are expressed as the medians, range 
and proportions. Statistical analysis to determine 
predictors of postoperative mortality was performed 
using the Chi-square test and Fisher exact probability 
test where appropriate.
Results
Baseline characteristics of patients are shown in Table 
1. Out of 52 patients, 31 were men and the median age 
was 69 years. In the majority of cases (28) preoperative 
endoscopic stenting was placed to manage obstructive 
jaundice. Resection procedures comprised 83% of 
cases (34 R0, 7 R1 and 2 R2 resections) and 9 included 
exploration laparotomy and palliative procedure only 
due to distant metastasis or advanced local disease 
(Figure 1.)
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Bile duct resection alone (hilar resection) was 
performed in 17 and bile duct resection coupled 
with right hepatectomy in 12 patient. Other types 
of hepatectomies, left and extended right, were less 
commonly done, in 3 and 2 cases, respectively. Portal vein 
resection and reconstruction was required in 4 cases to 
achieve adequate radicality. Other procedures included 
resections of primary tumor and metastasectomy (4 
cases), pancreaticoduodenectomy (2 cases), partial 
gastrectomy and transverse colon resection. In 
resectable cases, a bilio-digestive anastomosis was 
constructed by means of hepatico-jejunostomy in 37, 
and choledocho-jejunostomy in 6 cases. Intraoperative 
characteristics and outcomes are demonstrated in Table 
2. Median operative time was 420 minutes and average 
blood loss 800ml. Hospital stay ranged from 8 to 51 days 
with a median of 19 days.
Overall morbidity rate was 46% and posthepatectomy 
liver failure according to the 50:50 definition was the 
most common complication followed by intraabdominal 
sepsis and bile leakage. No intraoperative death was 
seen and three patients died of complications in a 
postoperative period (within 90 days from the day of 
surgery).
Liver failure associated with infectious complications 
was cause of death in all cases.
We conducted comparative univariate study which 
identified prognostic factors for severe (grade III or 
more) postoperative morbidity: age over 70 years, and 
preoperative jaundice that both showed significant 
association with outcome. Additional hepatectomy 
resulted in higher, although not statistically significant, 
morbidity rate while other variables were not associated 
with morbidity (Table 3). 
Discussion
Despite certain advances in chemotherapy, pCC remains 
a disease which can be cured only by radical surgical 
procedure. In the last 2 decades, there was a progress in 
treatment of pCC which can be attributed to significant 
decrease in surgical morbidity/mortality and expanded 
indications for radical procedure [4].
Our results presented here are comparable to those 
reported in literature and we adopted most recent 
recommendations in this field of surgery[5]. Thereby, 
we performed surgery in cases which were considered 
unresectable 10 years ago. This includes vascular 
infiltration and cases where combined resections 
of pancreas, stomach, liver or transverse colon are 
required.
Most authors agree that the goal of surgical treatment 
of pCC should be an R0 resection, therefore, radical 
intervention for type 3 and 4 tumors should include 
resection of the bile duct with lymphadenectomy of the 
hepatic hilum and right/left hepatectomy including the 
caudate lobe. However, treatment of type 1 or 2 tumors 
is more controversial and most authors suggest hilar 
resection alone, while the minority of them favor to add 
right hepatectomy to ensure adequate radicality[6].
In our research, over the time period studied, there 
was an increasing trend of performing a hilar resection 
coupled with hepatectomy especially when last 3 years 
are compared to the period between 2007 and 2009. 
Such a trend was reported in other research papers as 
well, and may be explained by the increasing number 
of evidence that hepatectomy improves R0 resection 
rates and yields better oncological outcomes compared 
to hilar resection alone. In addition, our results as well 
as relevant literature show that hepatectomy does 
not have significant negative effect on morbidity and 
mortality rates[7].
We want to highlight that rate of unresectable disease 
discovered at laparotomy was low (8%). This confirms 
evolution of more accurate preoperative investigation 
such as PET scan, EUS and ERCP.  Furthermore, in all 
unresectable cases, some type of palliative procedure 
was done. 
Liver transplantation for pCC was not performed in 
our institution and this is still under scientific and 
professional evaluation, but some excellent results 
have been reported [8].  Preoperative stent insertion 
is controversial since some authors argue that it may 
lead to unacceptable risk of cholangitis. However, we 
adopt the stance to manage biliary obstruction prior 
to surgery if technical and organizational capabilities 
allow it.
Conclusions
In conclusion, surgical treatment for pCC has been 
evolving and improved surgical technique led to 
expanded surgical indications, satisfactory morbidity/
mortality rates and promising oncologic outcome. The 
most important goal is to achieve R0 resection and 
preserve sufficient future liver volume. Considering 
relatively low incidence of pCC, future studies on larger 
number of patients are required to establish clear 
guidelines in management of this malignancy.
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 Patient, disease and procedural characteristics
 Patient Characteristics     All patients (n=52)
 Sex (M/F)      31/21
 Age (median, range), years    69 (31-82)
 BMI, kg/m2 (median, SD)     32.6 (±3.3)
 Child-Pugh (A/B)      44/8
 ASA score, median      2
 Cirrhosis (yes/no)     5/47
 Preoperative biliary stent (yes/no)    28/24
 Disease characteristics     All patients (n=48)
 Preoperative diagnosis( yes/no)*    41/11
 Type of tumor **
 - Type I       5 (9.6%)
 - Type II       10 (19.2%)
 - Type III       23 (44%)
 - Type IV       14 (26.4%)
 Curative/Palliative      43/9 (83%/17%)
 Type of resection
 R0       34
 R1       7
 R2       2
 Palliative      9  
 *Preoperative pathohistological confirmation
 ** According to Bismuth classification
Table 1. Baseline demographic and disease data
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 Operative and outcome results               
        All patients (N=52)
 Type of procedure
 - Hilar resection      17 
 - Hilar resection+ right hepatectomy   12
 - Hilar resection+ left hepatectomy   3
 - Hilar resection+ right hepatectomy   2
 - Palliative bilio-digestive bypass    9
 - Combined portal vein resections    4
 - Other       8
 Intraoperative factors     All patients (N=52)
 Operative time (median, min)    420/±112
 Estimated blood loss (ml)     800±180
 ICU stay ( median, range) days    6 (3-42)
 Hospital stay (median, range) days    19 (8-51)
 Outcomes
 90 days mortality     3(5.7%)
 Postoperative morbidity*     24(46%)
 1 year disease free survival    38 (74%) 
 Causes of postoperative morbidity   N=24
 - Liver failure      11     
 - Septic complications     7
 - Hemorrhage      2
 - Bile leakage      2
 - Other       2 
 Trends in additional hepatectomy**     p value
 -2007-2012       4/23  0.08
 -2012-2017      13/25 
 *According to Clavien-Dindo classification grade >III
 ** Prevalence of hepatectomy in two consecutive
      5-year periods for resectable cases
Table 2. Intraoperative factors and outcome
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 Predictors of severe morbidity
 Variable   No.patients  Morbidity (%)  P value
 Age,years         0.006
 <70    27   8 (29.6)
 >70    25   16 (64)  
 Preoperative jaundice        0.02
 yes    28   17 (60) 
 no    24   7 (29) 
 Concomitant hepatectomy       0.72
 yes    17   11 (64.7)
 no    17   9 (52.9) 
 Extent of liver resection        0.9
 <50%    11   7 (64)    
 >50%    6   4 (66) 
 Blood loss (ml)         0.82
 <800    29   13 (56) 
 >800    23   11 (47) 
 
Table 3. Univariate analysis of predictors of severe postoperative morbidity
 
Figure 1. Flowchart of the study
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(n=9)
Resected
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R0  n=34
R1  n=7
R2  n=2
Hilar resections
n=17
Hilar resections
+ hepatectomy
n=17
16
Acta Chirurgica CroaticaREVIEW
